181 related articles for article (PubMed ID: 10027497)
1. Carvedilol and the Food and Drug Administration approval process: an introduction.
Fisher LD; Moyé LA
Control Clin Trials; 1999 Feb; 20(1):1-15. PubMed ID: 10027497
[TBL] [Abstract][Full Text] [Related]
2. Carvedilol and the Food and Drug Administration (FDA) approval process: the FDA paradigm and reflections on hypothesis testing.
Fisher LD
Control Clin Trials; 1999 Feb; 20(1):16-39. PubMed ID: 10027498
[TBL] [Abstract][Full Text] [Related]
3. Coreg. New indication for heart failure drug.
Nursing; 2002 Feb; 32(2):18. PubMed ID: 11924159
[No Abstract] [Full Text] [Related]
4. End-point interpretation in clinical trials: the case for discipline.
Moyé LA
Control Clin Trials; 1999 Feb; 20(1):40-9; discussion 50-1. PubMed ID: 10027499
[TBL] [Abstract][Full Text] [Related]
5. Carvedilol [Coreg].
Kukin M
Compr Ther; 1997 Sep; 23(9):617-20. PubMed ID: 9285163
[No Abstract] [Full Text] [Related]
6. Carvedilol: a countermeasure to heart failure.
Barkman A; Pooler C
Dimens Crit Care Nurs; 2001; 20(5):11-6. PubMed ID: 22076514
[TBL] [Abstract][Full Text] [Related]
7. Carvedilol in the treatment of chronic heart failure.
Moe G
Expert Opin Pharmacother; 2001 May; 2(5):831-43. PubMed ID: 11336626
[TBL] [Abstract][Full Text] [Related]
8. Lack of evidence for peripheral alpha(1)- adrenoceptor blockade during long-term treatment of heart failure with carvedilol.
Kubo T; Azevedo ER; Newton GE; Parker JD; Floras JS
J Am Coll Cardiol; 2001 Nov; 38(5):1463-9. PubMed ID: 11691524
[TBL] [Abstract][Full Text] [Related]
9. Carvedilol offers women with heart problems the same clinical benefits as men.
Cardiovasc J S Afr; 2002; 13(2):84. PubMed ID: 12166361
[No Abstract] [Full Text] [Related]
10. Food and Drug Administration: Cardiovascular and Renal Drugs Advisory Committee, 98th meeting, January 6th-7th, 2003.
Fleming T; Borer J; Armstrong PW; Pfeffer M;
Circulation; 2003 Jan; 107(2):e9002-3. PubMed ID: 12538443
[No Abstract] [Full Text] [Related]
11. Carvedilol for heart failure.
Med Lett Drugs Ther; 1997 Sep; 39(1010):89-91. PubMed ID: 9323960
[No Abstract] [Full Text] [Related]
12. Beta-blockers in congestive heart failure: the pharmacology of carvedilol, a vasodilating beta-blocker and antioxidant, and its therapeutic utility in congestive heart failure.
Feuerstein G; Ruffolo RR
Adv Pharmacol; 1998; 42():611-5. PubMed ID: 9327976
[No Abstract] [Full Text] [Related]
13. Carvedilol prospective randomized cumulative survival (COPERNICUS) trial: carvedilol as the sun and center of the beta-blocker world?
Wollert KC; Drexler H
Circulation; 2002 Oct; 106(17):2164-6. PubMed ID: 12390940
[No Abstract] [Full Text] [Related]
14. [For the first time beta blockers are in direct comparison With carvedilol weak hearts beat longer].
MMW Fortschr Med; 2003 Jul; 145(27-28):60. PubMed ID: 14587195
[No Abstract] [Full Text] [Related]
15. Carvedilol.
Frishman WH
Indian Heart J; 1999; 51(3):325-32. PubMed ID: 10624077
[No Abstract] [Full Text] [Related]
16. Carvedilol.
Frishman WH
N Engl J Med; 1998 Dec; 339(24):1759-65. PubMed ID: 9845712
[No Abstract] [Full Text] [Related]
17. Carvedilol for heart failure, with care.
Cleland JG; Swedberg K
Lancet; 1996 May; 347(9010):1199-201. PubMed ID: 8622445
[No Abstract] [Full Text] [Related]
18. Carvedilol for heart failure: renewed interest in beta blockers.
Young JB
Cleve Clin J Med; 1997 Sep; 64(8):415-22. PubMed ID: 9308217
[TBL] [Abstract][Full Text] [Related]
19. [Severe heart failure--effects of carvedilol therapy. The Copernicus Study].
Kindermann M; Böhm M
Internist (Berl); 2002 Feb; 43(2):284-6. PubMed ID: 11963765
[No Abstract] [Full Text] [Related]
20. Landmark studies: the Australia/New Zealand Heart Failure Collaborative Group (ANZ) Trial and the US Carvedilol Trials Program.
Gilbert EM
Am J Cardiol; 2004 May; 93(9A):30B-4B. PubMed ID: 15144934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
